Phospholipase A2 activity in serum is induced during treatment with recombinant human interleukin-6 in patients with cancer.
Bertsch
T
T
Institut für Klinische Chemie, Klinikum der Stadt Mannheim, Universität Heidelberg, Germany.
Banks
R E
RE
Forbes
M A
MA
Aufenanger
J
J
Storr
M
M
Illingworth
J M
JM
Perren
T J
TJ
Selby
P J
PJ
Kattermann
R
R
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010741:Phospholipases A / Q000097:blood*; D054467:Phospholipases A2; D011994:Recombinant Proteins / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D015850:Interleukin-6; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D010741:Phospholipases A; D054467:Phospholipases A2